The clinical operations team involved with the Healey Platform Trial is truly going above and
The Martha Olson-Fernandez Foundation (MOFF) was very excited to hear that Novus Therapeutics had finalized
The New Times SLO recently published an article on The Martha Olson-Fernandez Foundation. The reporter,
Brief Overview CRISPR is a highly specific and efficient genome editing technology. CRISPR facilitates the
COVID-19 Impact on ALS Clinical Research as of July 23, 2020 Of the 95 ALS
Why read when you could watch short videos that teach you everything you need to
I. What is wrong with the current ALS clinical trial landscape? I am going to
The 8th Annual MOFF Golf Tournament took place at Cypress Ridge Golf Course on Oct.
Natalie Fernandez recently became a member of the Patient and Caregiver Advisory Committee (PCAC) at
1 in 300 is the lifetime risk of anyone developing ALS This 1/300 statistic is
MOFF attended the ALS/MND International Alliance Scientific Advisory Council Meeting on June 17th (at 4
The amyotrophic lateral sclerosis (ALS) diagnostic journey is unique to each individual. It has puzzled
Stay Connected The individuals and companies within the ALS Community are innovative and inspiring. Their
The National ALS Advocacy Conference (May 26, 2020 – June 3, 2020) The National ALS
What is the Healey Platform Trial? An ALS clinical trial that tests 5 different therapies
MOFF ALS Walk Team Thank you to all those who helped us raise $1,825.00! Your
Massachusetts General Hospital (MGH) has recently released incredibly useful webinars and Q&A sessions regarding living
MOFF encouraged ALS families to participate in Survey 1 of the ALS Focus Survey Program.
Username or email address *
Password *
Remember me Log in
Lost your password?
